We welcome enquiries from individuals interested in research on therapies for rare genetic disease. Our work sits at the interface of genomics, clinical medicine, and translational science, and we aim to build a genuinely multidisciplinary team. We particularly encourage clinicians, basic scientists, bioinformaticians, genetic counsellors, psychologists, and ethicists to get in touch. Progress in rare disease therapies requires collaboration across disciplines, and we welcome conversations with anyone whose expertise or interests align with the work of the group. If you are interested in working with us, please feel free to reach out.
We will shortly be advertising a fixed-term postdoc project to expand the possibilities of modifying mRNA via new exon skipping approaches using antisense oligonucleotides to target previously ineligible disease-causing genetic variants, alongside other therapeutic strategies (e.g., genome editing, gene addition).
If you are about to finish your PhD, have recently graduated or are already a few years into your postdoc and interested in the posiyion, please reach out.
We welcome enquiries from students interested in thesis projects or internships across disciplines. Projects may involve wet-lab research, computational work, or literature-based studies related to rare disease genomics and therapeutic development. Students who are interested in working with the group are encouraged to contact Dr Marlen Lauffer with a CV and a short motivation letter outlining their background and what they would be interested in working on.
We also welcome enquiries from individuals seeking a host institution for externally funded fellowships, such as Marie Skłodowska-Curie Fellowships or similar schemes. We are happy to discuss potential projects related to rare disease genomics, therapeutic development, and translational frameworks. Interested applicants are invited to contact Dr Marlen Lauffer with a CV, a short motivation letter, and a brief description of the project they would like to pursue.
We are always open to new collaborations across disciplines related to rare disease genomics and therapeutic development. Our work benefits from bringing together expertise from different fields, and we welcome conversations with researchers, clinicians, and other partners interested in this area. If you are interested in collaborating, please feel free to reach out to Dr Marlen Lauffer.